Search results

Search for "anticancer drugs" in Full Text gives 31 result(s) in Beilstein Journal of Nanotechnology.

Vinorelbine-loaded multifunctional magnetic nanoparticles as anticancer drug delivery systems: synthesis, characterization, and in vitro release study

  • Zeynep Özcan and
  • Afife Binnaz Hazar Yoruç

Beilstein J. Nanotechnol. 2024, 15, 256–269, doi:10.3762/bjnano.15.24

Graphical Abstract
  • anticancer drugs while mitigating the adverse effects of large dosage administration [6][7]. Additionally, it offers several advantages, such as controlled release, targeted drug delivery, and improved stability [8]. Moreover, nanoscale drug delivery systems hold great promise for specific cancer treatments
PDF
Album
Full Research Paper
Published 28 Feb 2024

Curcumin-loaded albumin submicron particles with potential as a cancer therapy: an in vitro study

  • Nittiya Suwannasom,
  • Netsai Sriaksorn,
  • Chutamas Thepmalee,
  • Krissana Khoothiam,
  • Ausanai Prapan,
  • Hans Bäumler and
  • Chonthida Thephinlap

Beilstein J. Nanotechnol. 2023, 14, 1127–1140, doi:10.3762/bjnano.14.93

Graphical Abstract
  • % (Huh-7, Figure 6B) and 58% to 32% (MCF-7, Figure 6D). The CUR-HSA-MPs showed lower cytotoxicity than free CUR at the same drug concentrations. This could be explained by its drug delivery process, which is a common feature of polymer anticancer drugs. Enhanced and sustained release of CUR is attributed
PDF
Album
Supp Info
Full Research Paper
Published 21 Nov 2023

Nanoarchitectonics of photothermal materials to enhance the sensitivity of lateral flow assays

  • Elangovan Sarathkumar,
  • Rajasekharan S. Anjana and
  • Ramapurath S. Jayasree

Beilstein J. Nanotechnol. 2023, 14, 988–1003, doi:10.3762/bjnano.14.82

Graphical Abstract
  • reduced graphene oxide (rGO), SERS imaging can be done along with photothermal therapy [84]. Recently, our group developed a multifunctional rGO–Au nanoscale architecture loaded with Raman dye and anticancer drugs for fluorescence/SERS imaging-guided breast cancer therapy. Under activation of a laser at
PDF
Album
Review
Published 04 Oct 2023

Nanotechnology – a robust tool for fighting the challenges of drug resistance in non-small cell lung cancer

  • Filip Gorachinov,
  • Fatima Mraiche,
  • Diala Alhaj Moustafa,
  • Ola Hishari,
  • Yomna Ismail,
  • Jensa Joseph,
  • Maja Simonoska Crcarevska,
  • Marija Glavas Dodov,
  • Nikola Geskovski and
  • Katerina Goracinova

Beilstein J. Nanotechnol. 2023, 14, 240–261, doi:10.3762/bjnano.14.23

Graphical Abstract
  • complexity of resistance and continuous cancer mutations. Co-delivery of TK inhibitors with anticancer drugs, immunotherapy, or gene-specific therapeutics to disrupt key resistance pathways, reactivate p53-mediated apoptosis, or inhibit cellular drug efflux are only a few examples of strategies used to fight
  • nanomedicines as tools for the targeted delivery of high concentrations of anticancer drugs at their site of action. Although designated as molecularly targeted therapies, the targeting of receptors by EGFR TKIs and other receptor inhibitors is not absolute. Once the EGFR TKIs are absorbed from the
  • targeted delivery may bring improvements in the efficacy of anticancer drugs and may aid in elucidating the beneficial synergistic combinations regarding lung cancer subtype treatment. Nanomedicines have the potential for (i) multivalent targeting and co-delivery of agents to endothelial cells, tumor
PDF
Album
Review
Published 22 Feb 2023

Alteration of nanomechanical properties of pancreatic cancer cells through anticancer drug treatment revealed by atomic force microscopy

  • Xiaoteng Liang,
  • Shuai Liu,
  • Xiuchao Wang,
  • Dan Xia and
  • Qiang Li

Beilstein J. Nanotechnol. 2021, 12, 1372–1379, doi:10.3762/bjnano.12.101

Graphical Abstract
  • possibility for the early diagnosis of cancer [7]. In recent decades, anticancer drugs have been developed in great number, enabling the control and treatment of many cancers to improve life quality and life span of people. Many approved anticancer drugs have significant effects on cell membrane proteins and
  • from measuring the alteration of cellular mechanics, which provides a guide for the innovation and development of anticancer drugs [11]. Atomic force microscopy (AFM) has matured into a forceful nanoscale platform for imaging biological samples and quantifying biomechanical properties of living cells
  • pancreatic cancer based on the differences in Young's modulus in the early stage. The effect of anticancer drugs on the nanomechanical property of PCCs The effect of anticancer drugs on the cellular mechanics provides a new way for drug evaluation and even provides credible guidance for the innovation and
PDF
Album
Supp Info
Full Research Paper
Published 14 Dec 2021

Biocompatibility and cytotoxicity in vitro of surface-functionalized drug-loaded spinel ferrite nanoparticles

  • Sadaf Mushtaq,
  • Khuram Shahzad,
  • Tariq Saeed,
  • Anwar Ul-Hamid,
  • Bilal Haider Abbasi,
  • Nafees Ahmad,
  • Waqas Khalid,
  • Muhammad Atif,
  • Zulqurnain Ali and
  • Rashda Abbasi

Beilstein J. Nanotechnol. 2021, 12, 1339–1364, doi:10.3762/bjnano.12.99

Graphical Abstract
  • (MFe2O4, where M = Fe, Co, Ni, or Zn) nanoparticles (NPs) were developed as carriers of the anticancer drugs doxorubicin (DOX) and methotrexate (MTX). Physical characterizations confirmed the formation of pure cubic structures (14–22 nm) with magnetic properties. Drug-loaded NPs exhibited tumor
  • excellent magnetic, colloidal, cytotoxic, and biocompatible aspects. However, detailed mechanistic, in vivo cytotoxicity, and magnetic-field-assisted studies are required to fully exploit these nanocarriers in therapeutic applications. Keywords: anticancer drugs; doxorubicin; drug carriers; in vitro
  • functionalized with anticancer drugs, such as doxorubicin (DOX) and methotrexate (MTX) via 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) chemistry. The samples were stored at room temperature for further experiments. Our aim was to compare the biocompatibility, colloidal stability, and in vitro
PDF
Album
Full Research Paper
Published 02 Dec 2021

Comprehensive review on ultrasound-responsive theranostic nanomaterials: mechanisms, structures and medical applications

  • Sepand Tehrani Fateh,
  • Lida Moradi,
  • Elmira Kohan,
  • Michael R. Hamblin and
  • Amin Shiralizadeh Dezfuli

Beilstein J. Nanotechnol. 2021, 12, 808–862, doi:10.3762/bjnano.12.64

Graphical Abstract
  • therapy; sonoporation; theranostics; ultrasound; ultrasound responsive nanomaterials; Review Introduction Smart drug delivery vehicles It is well known that the administration of most anticancer drugs can produce considerable systemic toxicity, which in some cases can be dose-limiting. Whether oral
  • anticancer drugs [139]. They can also be targeted to specific tissues through surface modification with different ligands [169][170]. Azmin et al. reviewed MB dynamics and the physical principles behind MBs, providing a theoretical basis for the development of MB-based theranostic systems [171]. Some
PDF
Album
Review
Published 11 Aug 2021

Recent progress in magnetic applications for micro- and nanorobots

  • Ke Xu,
  • Shuang Xu and
  • Fanan Wei

Beilstein J. Nanotechnol. 2021, 12, 744–755, doi:10.3762/bjnano.12.58

Graphical Abstract
  • structure had a higher motion speed and could effectively suppress lateral drifting motion. In addition, MNRs with a hollow tubular structure [29], which could facilitate drug delivery and realize effective treatment of cancer by loading and releasing anticancer drugs, were proposed and fabricated. At the
PDF
Album
Review
Published 19 Jul 2021

The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors

  • Nikola Geskovski,
  • Nadica Matevska-Geshkovska,
  • Simona Dimchevska Sazdovska,
  • Marija Glavas Dodov,
  • Kristina Mladenovska and
  • Katerina Goracinova

Beilstein J. Nanotechnol. 2021, 12, 375–401, doi:10.3762/bjnano.12.31

Graphical Abstract
PDF
Album
Review
Published 29 Apr 2021

Doxorubicin-loaded gold nanorods: a multifunctional chemo-photothermal nanoplatform for cancer management

  • Uzma Azeem Awan,
  • Abida Raza,
  • Shaukat Ali,
  • Rida Fatima Saeed and
  • Nosheen Akhtar

Beilstein J. Nanotechnol. 2021, 12, 295–303, doi:10.3762/bjnano.12.24

Graphical Abstract
  • Medical Toxicology Lab, Department of Zoology, Government College University Lahore, Lahore-54000, Pakistan 10.3762/bjnano.12.24 Abstract Two of the limitations associated with cancer treatment are the low efficacy and the high dose-related side effects of anticancer drugs. The purpose of the current
PDF
Album
Full Research Paper
Published 31 Mar 2021

PEG/PEI-functionalized single-walled carbon nanotubes as delivery carriers for doxorubicin: synthesis, characterization, and in vitro evaluation

  • Shuoye Yang,
  • Zhenwei Wang,
  • Yahong Ping,
  • Yuying Miao,
  • Yongmei Xiao,
  • Lingbo Qu,
  • Lu Zhang,
  • Yuansen Hu and
  • Jinshui Wang

Beilstein J. Nanotechnol. 2020, 11, 1728–1741, doi:10.3762/bjnano.11.155

Graphical Abstract
  • functionalization was supposed to attenuate the premature removal and loss of nanocarriers, and also to improve the targeting to the tumor site. The physical and chemical properties of CNTs-PEG-PEI were systematically characterized and doxorubicin (DOX), one of the most potent anticancer drugs applied in
  • attributed to their good dispersibility and comparably higher affinity to tumor cells due to the difunctionalization. In summary, the PEG- and PEI-conjugated CNTs may be used as novel nanocarriers and the findings will contribute to the rational design of multifunctional delivery vehicles for anticancer
  • drugs. Keywords: antitumor activity; cellular uptake; PEG functionalization; PEI functionalization; poly(ethylene glycol) (PEG); polyethylenimine (PEI); single-walled carbon nanotubes; Introduction To date, chemotherapy is the most common therapy for cancer treatment. However, the inability of
PDF
Album
Full Research Paper
Published 13 Nov 2020

Targeted therapeutic effect against the breast cancer cell line MCF-7 with a CuFe2O4/silica/cisplatin nanocomposite formulation

  • B. Rabindran Jermy,
  • Vijaya Ravinayagam,
  • Widyan A. Alamoudi,
  • Dana Almohazey,
  • Hatim Dafalla,
  • Lina Hussain Allehaibi,
  • Abdulhadi Baykal,
  • Muhammet S. Toprak and
  • Thirunavukkarasu Somanathan

Beilstein J. Nanotechnol. 2019, 10, 2217–2228, doi:10.3762/bjnano.10.214

Graphical Abstract
  • ). In vitro anticancer studies Cisplatin is a well-known efficient anticancer drug that binds to DNA blocking cell division. As with many anticancer drugs, cisplatin has off-target toxicity, mainly in the kidneys, liver, heart, nerves, and ears. In addition, most patients develop chemoresistance to
PDF
Album
Supp Info
Full Research Paper
Published 12 Nov 2019

Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activity

  • Sebastian Pieper,
  • Hannah Onafuye,
  • Dennis Mulac,
  • Jindrich Cinatl Jr.,
  • Mark N. Wass,
  • Martin Michaelis and
  • Klaus Langer

Beilstein J. Nanotechnol. 2019, 10, 2062–2072, doi:10.3762/bjnano.10.201

Graphical Abstract
  • , University of Kent, Canterbury CT2 7NJ, United Kingdom Institute for Medical Virology, University Hospital, Goethe-University, Paul Ehrlich-Straße 40, 60596 Frankfurt am Main, Germany 10.3762/bjnano.10.201 Abstract Background: Nanoparticles are under investigation as carrier systems for anticancer drugs
  • targeting can be achieved via the enhanced permeability and retention (EPR) effect, which is the consequence of increased leakiness of the tumour vasculature and a lack of lymph drainage [4]. Nano-sized drug carrier systems can also prolong the circulation time of anticancer drugs, protect them from
  • carriers for anticancer drugs. Here, we prepared and directly compared the effects of doxorubicin-loaded polylactic acid (PLA) and poly(lactic-co-glycolic acid) (PLGA) nanoparticles in neuroblastoma cells. PLA and PLGA are well-known ingredients of FDA- and EMA-approved drugs for human use [10][11] and are
PDF
Album
Full Research Paper
Published 29 Oct 2019

Synthesis and potent cytotoxic activity of a novel diosgenin derivative and its phytosomes against lung cancer cells

  • Liang Xu,
  • Dekang Xu,
  • Ziying Li,
  • Yu Gao and
  • Haijun Chen

Beilstein J. Nanotechnol. 2019, 10, 1933–1942, doi:10.3762/bjnano.10.189

Graphical Abstract
  • Natural products are the most easily accessible source of lead compounds of anticancer drugs [1]. In recent years, chemists have been seeking extensively for effective new chemical entities from natural products and their derivatives. Diosgenin (3β-hydroxy-5-spirostene, Di), is a conventional herbal
  • antiproliferative activity against HeLa cells, which is close to that of the clinical anticancer agent paclitaxel [14]. These successful examples demonstrated that the steroidal structure of Di is promising for the discovery of new anticancer drugs. Liposomes that usually consist of phospholipids and are stabilized
PDF
Album
Supp Info
Full Research Paper
Published 24 Sep 2019

Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells

  • Hannah Onafuye,
  • Sebastian Pieper,
  • Dennis Mulac,
  • Jindrich Cinatl Jr.,
  • Mark N. Wass,
  • Klaus Langer and
  • Martin Michaelis

Beilstein J. Nanotechnol. 2019, 10, 1707–1715, doi:10.3762/bjnano.10.166

Graphical Abstract
  • important role in cancer cell drug resistance as a highly promiscuous transporter that mediates the cellular efflux of a wide range of structurally different substrates including many anticancer drugs. Different studies have reported that nanometer-sized drug carrier systems can bypass efflux-mediated drug
  • therefore result in toxicity as a consequence of a modified body distribution of anticancer drugs (and other drugs that are co-administered for conditions other than cancer), xenobiotics, and other molecules. Hence, the use of drug carrier systems to bypass ABC transporter-mediated drug efflux is
PDF
Album
Supp Info
Full Research Paper
Published 14 Aug 2019

The systemic effect of PEG-nGO-induced oxidative stress in vivo in a rodent model

  • Qura Tul Ain,
  • Samina Hyder Haq,
  • Abeer Alshammari,
  • Moudhi Abdullah Al-Mutlaq and
  • Muhammad Naeem Anjum

Beilstein J. Nanotechnol. 2019, 10, 901–911, doi:10.3762/bjnano.10.91

Graphical Abstract
  • a chitosan 3D scaffold and enhanced its bioactivity, mechanical properties, and pore formation with GO for optimal bone tissue engineering [15]. Zhang et al. improved the chemotherapy efficacy of anticancer drugs with polyethyleneimine (PEI)-grafted GO [16]. Liu et al. discussed the antibacterial
  • has been utilized as a potent radiotracer and drug-delivery agent in vivo using positron emission tomography (PET) imaging by Jang and co-workers [31]. Liu et al. [32][33] used PEG for the first time to functionalize GO, which can then be use as a vehicle for anticancer drugs such as doxorubicin. The
PDF
Album
Full Research Paper
Published 18 Apr 2019

Polydopamine-coated Au nanorods for targeted fluorescent cell imaging and photothermal therapy

  • Boris N. Khlebtsov,
  • Andrey M. Burov,
  • Timofey E. Pylaev and
  • Nikolai G. Khlebtsov

Beilstein J. Nanotechnol. 2019, 10, 794–803, doi:10.3762/bjnano.10.79

Graphical Abstract
  • . Meanwhile different imaging and therapeutic agents can be loaded into the shell of multifunctional nanocomposites. Various AuNR-based nanocomposites loaded with anticancer drugs [17][18][19], photodynamic dyes [20][21], MRI contrast agents [22] and many others ligands [23][24] have already been reported for
PDF
Album
Supp Info
Full Research Paper
Published 01 Apr 2019

Cytotoxicity of doxorubicin-conjugated poly[N-(2-hydroxypropyl)methacrylamide]-modified γ-Fe2O3 nanoparticles towards human tumor cells

  • Zdeněk Plichta,
  • Yulia Kozak,
  • Rostyslav Panchuk,
  • Viktoria Sokolova,
  • Matthias Epple,
  • Lesya Kobylinska,
  • Pavla Jendelová and
  • Daniel Horák

Beilstein J. Nanotechnol. 2018, 9, 2533–2545, doi:10.3762/bjnano.9.236

Graphical Abstract
  • side effects are considered to be the main drawback of conventional anticancer drugs. The drug dosage is significantly limited and thus complete elimination of tumor cells in cancer patients is not guaranteed. Among antitumor drugs, special attention has been paid to the anthracycline antibiotic
PDF
Album
Full Research Paper
Published 25 Sep 2018

Nanoparticle delivery to metastatic breast cancer cells by nanoengineered mesenchymal stem cells

  • Liga Saulite,
  • Karlis Pleiko,
  • Ineta Popena,
  • Dominyka Dapkute,
  • Ricardas Rotomskis and
  • Una Riekstina

Beilstein J. Nanotechnol. 2018, 9, 321–332, doi:10.3762/bjnano.9.32

Graphical Abstract
  • drug efflux transporter P-glycoprotein, which ensures rapid excretion of toxic substances from MSCs. Thus, MSCs are an excellent vector for low cytotoxicity anticancer drugs [4]. Sadhukha et al. demonstrated that nanoengineered MSCs home to A549 lung cancer in vivo and remain there for at least 3 h
  • , which could be sufficient time to release drugs into the tumour. The encapsulation of NP-linked anticancer drugs could ensure metered drug release in tumours [2]. QD linkage to photosensitisers, such as chlorin e6, causes damage to MiaPaCa2 cancer cells via light-induced cytotoxicity, demonstrating a
PDF
Album
Supp Info
Full Research Paper
Published 29 Jan 2018

Development of polycationic amphiphilic cyclodextrin nanoparticles for anticancer drug delivery

  • Gamze Varan,
  • Juan M. Benito,
  • Carmen Ortiz Mellet and
  • Erem Bilensoy

Beilstein J. Nanotechnol. 2017, 8, 1457–1468, doi:10.3762/bjnano.8.145

Graphical Abstract
  • during chemotherapy. Amphiphilic cyclodextrins are favored oligosaccharides as drug delivery systems for anticancer drugs, having the ability to spontaneously form nanoparticles without surfactant or co-solvents. In the past few years, polycationic, amphiphilic cyclodextrins were introduced as effective
  • as well as other lipophilic anticancer drugs for cancer therapy. In addition, by formulating with anionic and cationic amphiphilic CDs, it will be possible to enhance anticancer activity of drugs, overcoming the problem of surfactant-induced toxicity. Finally, it can be said that polycationic
PDF
Album
Full Research Paper
Published 13 Jul 2017

Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment

  • Cem Varan and
  • Erem Bilensoy

Beilstein J. Nanotechnol. 2017, 8, 1446–1456, doi:10.3762/bjnano.8.144

Graphical Abstract
  • , facilitating chemotherapy administration to prevent recurrence of the tumor at the time of tumor tissue removal by surgical operation. Among the anticancer drugs that are used in clinics, the taxane family of drugs such as paclitaxel and docetaxel are known to be highly effective against a variety of cancer
  • often cause serious side effects. Thus, the necessity of a safe and effective formulation and drug delivery approach emerges for these potent anticancer drugs from the taxane family [10][11][12][13]. Successful treatment of brain cancer is dependent on the efficient and safe delivery of chemotherapeutic
PDF
Album
Full Research Paper
Published 12 Jul 2017

Nanoscale isoindigo-carriers: self-assembly and tunable properties

  • Tatiana N. Pashirova,
  • Andrei V. Bogdanov,
  • Lenar I. Musin,
  • Julia K. Voronina,
  • Irek R. Nizameev,
  • Marsil K. Kadirov,
  • Vladimir F. Mironov,
  • Lucia Ya. Zakharova,
  • Shamil K. Latypov and
  • Oleg G. Sinyashin

Beilstein J. Nanotechnol. 2017, 8, 313–324, doi:10.3762/bjnano.8.34

Graphical Abstract
  • toxicity as well as to minimize drug degradation and to provide a controllable drug release [51][52][53]. The modification of nanostructures with conjugated π–π fragments leads to the absorption of anticancer drugs via π–π stacking interaction and increases the drug-loading capacity of nanoscale soft
PDF
Album
Supp Info
Full Research Paper
Published 01 Feb 2017

Chitosan-based nanoparticles for improved anticancer efficacy and bioavailability of mifepristone

  • Huijuan Zhang,
  • Fuqiang Wu,
  • Yazhen Li,
  • Xiping Yang,
  • Jiamei Huang,
  • Tingting Lv,
  • Yingying Zhang,
  • Jianzhong Chen,
  • Haijun Chen,
  • Yu Gao,
  • Guannan Liu and
  • Lee Jia

Beilstein J. Nanotechnol. 2016, 7, 1861–1870, doi:10.3762/bjnano.7.178

Graphical Abstract
  • effects of MCNs could be due to the synergistic effects of Cs and MIF. Previous studies using other cancer cell lines and other anticancer drugs also found the anticancer effects of Cs and the synergistic interplay of CNs and anticancer drugs [35][36]. Besides, the sustained release of MIF from the CNs
PDF
Album
Full Research Paper
Published 28 Nov 2016

Green and energy-efficient methods for the production of metallic nanoparticles

  • Mitra Naghdi,
  • Mehrdad Taheran,
  • Satinder K. Brar,
  • M. Verma,
  • R. Y. Surampalli and
  • J. R. Valero

Beilstein J. Nanotechnol. 2015, 6, 2354–2376, doi:10.3762/bjnano.6.243

Graphical Abstract
  • delivery of anticancer drugs have been demonstrated [24][25][26][27][28][29][30][31][32][33][34]. In Table 1, the application of different metallic NPs is summarized. Green Chemistry metrics Green Chemistry is gradually integrated into new scientific and industrial developments to be aligned with the
PDF
Album
Review
Published 10 Dec 2015

Natural and artificial binders of polyriboadenylic acid and their effect on RNA structure

  • Giovanni N. Roviello,
  • Domenica Musumeci,
  • Valentina Roviello,
  • Marina Pirtskhalava,
  • Alexander Egoyan and
  • Merab Mirtskhulava

Beilstein J. Nanotechnol. 2015, 6, 1338–1347, doi:10.3762/bjnano.6.138

Graphical Abstract
  • in the field of the development of novel anticancer drugs, we report a description of different classes of molecules characterized by their ability to interact with poly(rA). Some of them are of natural origin, as in the case of neomycin, palmatine, berberine, chelerythrine and other alkaloids and
PDF
Album
Review
Published 17 Jun 2015
Other Beilstein-Institut Open Science Activities